MedTrace Logo

Cardiac Magnetic Resonance Tissue Characterization in COVID-19 Survivors

NCT05164744 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 510

Last updated 2026-01-22

No results posted yet for this study

Summary

The purpose of this study is to test if visualizing the heart with cardiac MRI/echo will be important in the understanding cardiac function and prediction of cardiopulmonary symptoms, physical effort tolerance, and outcomes in COVID-19 survivors. If successful, the research will allow us to identify the causes of lasting cardiopulmonary symptoms and begin developing cardiac and lung directed therapies accordingly.

Conditions

  • COVID-19 Pneumonia
  • COVID-19
  • COVID-19 Respiratory Infection
  • COVID-19 Acute Respiratory Distress Syndrome
  • COVID-19 Lower Respiratory Infection
  • COVID-19 Acute Bronchitis
  • Coronavirus Disease 2019

Interventions

DIAGNOSTIC_TEST

Cardiac MRI

Patients participate in an NIH funded cardiac MRI to assess their symptoms.

DIAGNOSTIC_TEST

Echocardiogram

Patients participate in an NIH funded cardiac echocardiogram to assess their symptoms.

DIAGNOSTIC_TEST

6-minute walk test

Patients participate in a 6-minute walk test to assess their symptoms.

DIAGNOSTIC_TEST

Questionnaire

Patients answer a survey-based questionnaire to assess their symptoms.

Sponsors & Collaborators

  • National Heart, Lung, and Blood Institute (NHLBI)

    collaborator NIH

  • Weill Medical College of Cornell University

    lead OTHER

Principal Investigators

  • Jiwon Kim, MD · Weill Medical College of Cornell University

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-07-01
Primary Completion
2026-07-30
Completion
2026-07-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05164744 on ClinicalTrials.gov